United States
I help product, compliance, operations, and GTM leaders turn AI initiatives into governed operating models that improve execution, unlock growth, and withstand executive, buyer, audit, and regulatory scrutiny. Core Capabilities: · AI Strategy & Business Transformation: Define where agentic AI creates value, how workflows must change, and the operating models required for AI unit economics, control points, and human review. · GRC & AI Governance Architecture: Design governance models for AI-enabled workflows, including audit trails, HITL review, segregation of duties, evidence packs, vendor risk, and control mapping across HIPAA, SOC 2, ISO 27001/42001, NIST AI RMF, EU AI Act, FINRA/SOX, and e-discovery. · Audit, Security & Regulatory Readiness: Translate complex agentic behavior into risk, control, and evidence documentation. Apply adversarial review methods to stress-test AI control frameworks before external audit or buyer scrutiny. · AI Product & Workflow Architecture: Translate regulated workflows into AI product requirements, compliance controls, agentic patterns, deployment roadmaps, and acceptance criteria. · Model Risk, Evaluation & Assurance: Define safeguards for data quality, grounding, faithfulness, lineage, and measurable acceptance testing before outputs enter regulated workflows. · Regulated Go-to-Market Enablement: Position governed AI capabilities for commercialization by aligning product claims, compliance requirements, evidence expectations, and vendor audit readiness. Operating Background: I have built, scaled, turned around, and sold healthcare technology and enterprise services businesses across SaaS, analytics, managed care, IT services, and regulated technology markets. My AI work is grounded in operator experience: AI is not just a tool rollout; it is a business transformation, evaluation, governance, and risk-control discipline. Highlights: · Managed a $90M+ P&L and 1,100-person global team for a national health-plan account · Grew annualized account revenue from $28M to $51M in year one and $80M in year two Earned Cognizant’s “Account of the Year” recognition out of 1,500+ healthcare accounts · Built and sold healthcare technology companies to IMS Health/IQVIA and OptumInsight · Raised ~$16M in seed and Series A funding across healthcare technology ventures · Scaled a health-tech company to 100+ employees and built an award-winning national provider cost-and-quality search platform used by 25M+ consumers.
Help regulated enterprises scale agentic AI workflows with governance, validation, and audit-ready evidence so AI can move into core operations or commercialization without unmanaged risk. Partner with cross-functional leadership to combine GRC architecture, agentic workflow redesign, and vendor oversight, ensuring AI adoption delivers measurable ROI, strict compliance, reliability and defensible execution. Core Capabilities: AI Strategy & Business Transformation · GRC Architecture · Agentic Workflow Governance · Model Behavior & Eval Frameworks · AI Product Architecture · Regulated GTM Enablement
Re-engaged in 2026 after earlier VenAdvisory consulting work to support Giva’s regulated healthcare ITSM growth, enterprise positioning, and AI workflow strategy for HIPAA-sensitive environments. • Enterprise healthcare growth: Supported acquisition of a 670-bed, 1,000+ provider health-system ITSM contract by tailoring the product offering to healthcare procurement, regulated workflows, and compliance requirements. • Regulated GTM validation: Led strategic product-market validation with 15 healthcare CIOs, refining positioning for HIPAA-compliant ITSM in complex healthcare procurement environments. • AI roadmap & agentic workflow strategy: Advised leadership on AI roadmap priorities, governance guardrails, evidence-pack architecture, and agentic workflow automation opportunities for regulated ITSM use cases. • Healthcare compliance architecture: Guided ITSM workflow redesign for HIPAA alignment, Epic integration requirements, and enterprise buyer expectations in regulated healthcare settings.
Built and led InteliGems Labs as an AI product company focused on governed AI platforms for regulated enterprises needing explainable workflows, audit-ready evidence, and control over sensitive data, logic, and IP. Led a distributed 10-person product, marketing, and engineering team across North America, Europe, and Asia. • Private AI architecture: Led product strategy, requirements definition, and solution architecture with CTO/engineering for Odyssey AI 3.0, Agent Fleet v2.0, DutyGuard Control Tower™, Odyssey Scout™, and QA Evaluator™, using RAG, private VPC/on-prem patterns, open-source components, and multimodal transcript-intelligence architecture to support governed AI workflows. • Governed agentic workflows: Designed agent orchestration patterns for least-privilege execution, runtime guardrails, human-in-the-loop approvals, segregation of duties, MCP-based integrations, SourceSnips™ citations, audit trails, and evidence export across legal, compliance, procurement, and regulated enterprise workflows. • Evaluation, evidence & audit traceability: Designed QA Evaluator™ frameworks for groundedness, faithfulness, explainability, replayable traces, validation runbooks, and compliance packs mapped to SOC 2, HIPAA, ISO 27001, export controls, and the EU AI Act. • Reported case-study outcomes: Published Odyssey AI case studies reported 94% faster e-discovery review, 85% fewer privilege errors, 90% lower review costs, 98% faster export-control screening, 89% fewer false positives, and RFP/DDQ workflows with explainable answers, HITL/SoD governance, CRM/email handoffs, and source traceability. Transitioned the product-company chapter in Oct. 2025; the governance concepts, MCP patterns, agent architectures, and evaluation frameworks now inform my fractional AI executive and GRC consulting practice.
Advised founders, investors, and C-suite teams across healthcare technology, digital health, medical devices, therapeutics, and enterprise technology on GTM strategy, market validation, product positioning, and commercialization risk. • AccelerateGTM® framework: Designed a commercialization methodology combining customer validation, digital MVP testing, moderated buyer interviews, key opinion leader (KOL) recruiting, pricing, ROI modeling, and sales analytics, reducing time-to-market by ~30% and customer-acquisition costs by up to 47%. • Portfolio advisory: Led GTM, new product development, and product marketing across telemedicine, EHR, HIE, RCM, specialty-pharma access, prior-authorization workflows, GPOs, and pharmaceutical supply-chain markets. • Representative clients: Supported McKesson/RelayHealth, Emdeon, Microsoft Healthcare, Johnson & Johnson/DePuy, Breg, Clinicient, BTG/Boston Scientific, SRI International, UW Medicine, IHA, and Giva. • Selected fractional engagements: Led advisory work for Corrona/CorEvitas on clinical-registry and regulatory-grade real-world-evidence commercialization; Sapiens Data Science on genomics-informed health-risk score commercialization; Catalia Health/Mabu on conversational-AI healthcare robotics; and SingFit on cognitive-health digital therapeutics. • Investor and sales readiness: Helped teams refine target segments, buyer messaging, business cases, enterprise sales strategy, and diligence narratives for venture rounds, strategic partnerships, and M&A.
Recruited by the CEO for a full-time interim assignment to restructure marketing, reposition Edifecs across healthcare and adjacent markets, and improve demand generation, accountability, and execution speed. • Marketing restructuring & cost reduction: Rebuilt the function, upgraded personnel, implemented lean operating practices, and migrated to a 24/7 onshore/offshore model; reduced marketing overhead from 9% to 6% of revenue, generating $1.6M+ in savings. • GTM & demand generation: Repositioned solutions across payer, provider, government, international, and adjacent non-healthcare markets; increased trade-show MQLs by 275% in six months through leaderboard-driven pre-show outreach, progress dashboards, and targeted campaigns. • Brand repositioning & digital strategy: Rewrote the company story, led a third-generation website and collateral refresh, introduced a strategic advisory board, and shifted feature-driven materials into persona-based content, customer journey maps, and messaging focused on compliance, ACOs, population health, value-based care, and ICD-10.